innoscripta SE (XTER:1INN) Research & Development: € Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:1INN innoscripta SE XTER:1INN
29 GF Score
Price €87.30
! 2 Warning Signs
View Full Analysis

What is innoscripta SE Research & Development?

innoscripta SE XTER:1INN 29 Research & Development is € Mil as of Jun. 2026. GuruFocus rates XTER:1INN with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. innoscripta SE's Research & Development for the three months ended in Jun. 2026 was € Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was € Mil.

innoscripta SE  (XTER:1INN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

innoscripta SE Research & Development Related Terms

innoscripta SE Research & Development Historical Data

* Premium members only.

The historical data trend for innoscripta SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

innoscripta SE Research & Development Chart

innoscripta SE Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
- - - - -

innoscripta SE Quarterly Data
Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -
XTER:1INN
29GF Score
innoscripta SE XTER:1INN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

innoscripta SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was € Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of € Mil mean?
innoscripta SE (XTER:1INN) has a Research & Development of € Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on innoscripta SE and its competitors.
Is innoscripta SE's Research & Development too high?
innoscripta SE's current Research & Development is € Mil. Overall, innoscripta SE has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does innoscripta SE's Research & Development compare to CRM and SHOP?
innoscripta SE's Research & Development of € Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on innoscripta SE and its competitors. innoscripta SE's current Research & Development is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is innoscripta SE stock overvalued right now?
innoscripta SE (XTER:1INN) has a current Research & Development of € Mil. The current Research & Development is € Mil. innoscripta SE's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For innoscripta SE (XTER:1INN), the current Research & Development is € Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

innoscripta SE Business Description

Address Bahnhofstr. 17, Tutzing, BY, DEU, 82327
innoscripta SE is a software company specializing in cloud-based compliance software for research and development. The company provides R&D tax incentives consulting.
29GF Score

Get the complete analysis for XTER:1INN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.30
Price